Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 5Uterine Cervical Neoplasms 3Uterine Cervical Dysplasia 2Papillomavirus Infections 2Melanoma 2Hemangioma, Capillary 2Breast Neoplasms 2Vulvar Neoplasms 1Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1Virus Diseases 1Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Skin Neoplasms 1Sexually Transmitted Diseases 1Precancerous Conditions 1Pigmentation Disorders 1Ovarian Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hemangioma 1HPV 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Condylomata Acuminata 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1Carcinoma in Situ 1

Interventions

Gels 3hecolin 1berdazimer sodium 1Vaccines, Synthetic 1Vaccines 1VP-102 1Therapies, Investigational 1Podophyllin 1Papillomavirus Vaccines 1Omiganan 1Imiquimod 1Human Papillomavirus Recombinant Vaccine nonavalent 1Cryotherapy 1Cantharidin 13-ingenyl angelate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Condylomata Acuminata × Imiquimod × Clear all
NCT02482428 2021-01-05

Efficacy and Tolerability of Topical LFX453 for External Genital Warts

Novartis

Phase 2 Completed
88 enrolled 10 charts

Condylomata Acuminata, Sexually Transmitted Diseases, Virus Diseases, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡